Mechanistic insights into the inhibition of drug-resistant cytomegalovirus by letermovir and ganciclovir. (PubMed, Br J Pharmacol) - Nov 14, 2025 - "Despite different mechanisms of action, both drugs inhibited the spread of newly emerging resistant viruses around wild-type CMV-infected lesions during letermovir/ganciclovir treatment, suggesting the practical use of both drugs and strategies for treating drug-resistant CMV."
Journal • Cytomegalovirus Infection • Infectious Disease
|
|
Atsuko Shiraki; Kaoru Sakai; Kazunari Tanabe; Kimiyasu Shiraki; Masaya Takemoto; Motoko Yanagita; Noriaki Sato; Seiya Imoto; Tohru Daikoku; Yoshinori Takemura
|